Abstract
At JADPRO Live 2019, Krista M. Rubin, MS, FNP-BC, and Anthony J. Olszanski, MD, RPh, reviewed the basic concepts of immunotherapy and the current treatment landscape, and discussed emerging data for immune checkpoint inhibitor–based combinations that are being explored in late-stage clinical trials.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have